These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
213 related items for PubMed ID: 2208117
21. Inhibition of p185c-erbB-2 proto-oncogene expression by antisense oligodeoxynucleotides down-regulates p185-associated tyrosine-kinase activity and strongly inhibits mammary tumor-cell proliferation. Brysch W, Magal E, Louis JC, Kunst M, Klinger I, Schlingensiepen R, Schlingensiepen KH. Cancer Gene Ther; 1994 Jun; 1(2):99-105. PubMed ID: 7621247 [Abstract] [Full Text] [Related]
22. Reduction of erbB2 gene product in mamma carcinoma cell lines by erbB2 mRNA-specific and tyrosine kinase consensus phosphorothioate antisense oligonucleotides. Bertram J, Killian M, Brysch W, Schlingensiepen KH, Kneba M. Biochem Biophys Res Commun; 1994 Apr 15; 200(1):661-7. PubMed ID: 7909438 [Abstract] [Full Text] [Related]
23. Inhibition of chronic myelogenous leukemia cells harboring a BCR-ABL B3A2 junction by antisense oligonucleotides targeted at the B2A2 junction. Mahon FX, Ripoche J, Pigeonnier V, Jazwiec B, Pigneux A, Moreau JF, Reiffers J. Exp Hematol; 1995 Dec 15; 23(14):1606-11. PubMed ID: 8542954 [Abstract] [Full Text] [Related]
24. Antisense down-regulation of metallothionein induces growth arrest and apoptosis in human breast carcinoma cells. Abdel-Mageed A, Agrawal KC. Cancer Gene Ther; 1997 Dec 15; 4(3):199-207. PubMed ID: 9171939 [Abstract] [Full Text] [Related]
25. [Inhibition of c-sis protein synthesis and cell growth with antisense oligonucleotides in human glioma cells]. Nitta T, Sato K. No Shinkei Geka; 1992 Aug 15; 20(8):857-63. PubMed ID: 1508312 [Abstract] [Full Text] [Related]
26. Antigene and antiproliferative effects of a c-myc-targeting phosphorothioate triple helix-forming oligonucleotide in human leukemia cells. McGuffie EM, Pacheco D, Carbone GM, Catapano CV. Cancer Res; 2000 Jul 15; 60(14):3790-9. PubMed ID: 10919652 [Abstract] [Full Text] [Related]
27. Inhibition of growth of human breast carcinoma cells by an antisense oligonucleotide targeted to the transferrin receptor gene. Yang DC, Jiang XP, Elliott RL, Head JF. Anticancer Res; 2001 Jul 15; 21(3B):1777-87. PubMed ID: 11497259 [Abstract] [Full Text] [Related]
28. Antisense inhibition of single copy N-myc expression results in decreased cell growth without reduction of c-myc protein in a neuroepithelioma cell line. Rosolen A, Whitesell L, Ikegaki N, Kennett RH, Neckers LM. Cancer Res; 1990 Oct 01; 50(19):6316-22. PubMed ID: 2205380 [Abstract] [Full Text] [Related]
29. Quantifying c-myc expression in c-myc antisense phosphorothioate oligodeoxynucleotide-treated leukemic and colon cancer cell lines. Li BD, Budnick RM, Russo CA, Anderson GR, Stewart CC. J Surg Res; 1995 Oct 01; 59(4):485-92. PubMed ID: 7564322 [Abstract] [Full Text] [Related]
30. Opposite functions of jun-B and c-jun in growth regulation and neuronal differentiation. Schlingensiepen KH, Schlingensiepen R, Kunst M, Klinger I, Gerdes W, Seifert W, Brysch W. Dev Genet; 1993 Oct 01; 14(4):305-12. PubMed ID: 8222345 [Abstract] [Full Text] [Related]
31. [Inhibition of Bcl-2 expression in HL60 cells by incubation with antisense phosphorothioate oligodeoxynucleotides]. Lin Y, Lu L, Hu J. Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 1999 Feb 10; 16(1):12-5. PubMed ID: 9949233 [Abstract] [Full Text] [Related]
32. Inhibition of vascular smooth muscle cell proliferation in vitro and in vivo by c-myc antisense oligodeoxynucleotides. Bennett MR, Anglin S, McEwan JR, Jagoe R, Newby AC, Evan GI. J Clin Invest; 1994 Feb 10; 93(2):820-8. PubMed ID: 8113414 [Abstract] [Full Text] [Related]
33. Alterations of c-myc expression by antisense oligodeoxynucleotides enhance the induction of apoptosis in HL-60 cells. Kimura S, Maekawa T, Hirakawa K, Murakami A, Abe T. Cancer Res; 1995 Mar 15; 55(6):1379-84. PubMed ID: 7882339 [Abstract] [Full Text] [Related]
34. Antiproliferative effect of c-myc antisense phosphorothioate oligodeoxynucleotides in malignant glioma cells. Broaddus WC, Chen ZJ, Prabhu SS, Loudon WG, Gillies GT, Phillips LL, Fillmore H. Neurosurgery; 1997 Oct 15; 41(4):908-15. PubMed ID: 9316053 [Abstract] [Full Text] [Related]
35. Antisense oligodeoxynucleotides against the BZLF1 transcript inhibit induction of productive Epstein-Barr virus replication. Diabata M, Enzinger EM, Monroe JE, Kilkuskie RE, Field AK, Mulder C. Antiviral Res; 1996 Mar 15; 29(2-3):243-60. PubMed ID: 8739603 [Abstract] [Full Text] [Related]
36. Antiapoptotic effect of c-fes protooncogene during granulocytic differentiation. Ferrari S, Manfredini R, Tagliafico E, Grande A, Barbieri D, Balestri R, Pizzanelli M, Zucchini P, Citro G, Zupi G. Leukemia; 1994 Apr 15; 8 Suppl 1():S91-4. PubMed ID: 8152313 [Abstract] [Full Text] [Related]
37. Non-sequence-specific inhibition of transferrin receptor expression in HL-60 leukemia cells by phosphorothioate oligodeoxynucleotides. Ho PT, Ishiguro K, Wickstrom E, Sartorelli AC. Antisense Res Dev; 1991 Apr 15; 1(4):329-42. PubMed ID: 1821654 [Abstract] [Full Text] [Related]
38. Inhibition of protooncogene expression by antisense oligodeoxynucleotides: biological and therapeutic implications. Calabretta B. Cancer Res; 1991 Sep 01; 51(17):4505-10. PubMed ID: 1873794 [No Abstract] [Full Text] [Related]
39. Cellular effects of antisense c-myc oligodeoxynucleotides are delivery dependent. Koo EW, Edelman ER. Drug Deliv; 1996 Sep 01; 3(3):149-54. PubMed ID: 26790910 [Abstract] [Full Text] [Related]
40. Normal and leukemic hematopoietic cells manifest differential sensitivity to inhibitory effects of c-myb antisense oligodeoxynucleotides: an in vitro study relevant to bone marrow purging. Calabretta B, Sims RB, Valtieri M, Caracciolo D, Szczylik C, Venturelli D, Ratajczak M, Beran M, Gewirtz AM. Proc Natl Acad Sci U S A; 1991 Mar 15; 88(6):2351-5. PubMed ID: 2006173 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]